• $180,755.00
    Market Cap
  • 0.00%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2022
12/31/2021
12/31/2020
Income Statement
Total Operating Revenue
135,355
+85.15%
73,105
-55.91%
165,796
N/A
Cost of Revenue
9,990
-33.33%
14,985
-77.08%
65,369
N/A
Gross Profit
125,365
+115.70%
58,120
-42.13%
100,427
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
N/A
N/A
0
+100.00%
-3,283
N/A
Depreciation and Amortization Expense
646,912
-0.24%
648,492
-0.42%
651,247
N/A
Total Operating Expenses
3.4M
+48.37%
2.3M
-24.16%
3.0M
N/A
Operating Profit
-3.3M
+46.61%
-2.2M
-23.54%
-2.9M
N/A
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
-1.3M
+40.36%
-941,566
-54.80%
-2.1M
N/A
Interest Income and Expense and Net
-1.3M
+40.36%
-941,566
-54.80%
-2.1M
N/A
Total Nonoperating Income and Expense
-15.2M
+1,631.72%
-878,347
-134.90%
2.5M
N/A
Income before Taxes
-18.5M
+495.02%
-3.1M
+684.89%
-395,584
N/A
Income Taxes
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-18.5M
+495.02%
-3.1M
+684.89%
-395,584
N/A
Net Income from Continuing Operations Applicable to Common
-18.5M
+495.02%
-3.1M
+684.89%
-395,584
N/A
Basic EPS and Net Income
-0.13
+160.00%
-0.05
+66.67%
-0.03
N/A
Diluted EPS and Net Income
-0.13
+160.00%
-0.05
+66.67%
-0.03
N/A
Basic Weighted Average Shares
139.2M
+132.64%
59.8M
+389.83%
12.2M
N/A
Diluted Weighted Average Shares
139.2M
+132.64%
59.8M
+389.83%
12.2M
N/A
Balance Sheet
Cash and Cash Equivalents
98
-99.89%
85,936
+540.36%
13,420
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
98
-99.89%
85,936
+540.36%
13,420
N/A
Total Current Assets
15,822
-83.32%
94,855
+105.37%
46,187
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
88,214
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
1,580
N/A
Total Long-Term Assets
N/A
N/A
N/A
N/A
1,580
N/A
Total Assets
1.3M
-36.17%
2.0M
-23.01%
2.6M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
7.2M
-0.39%
7.2M
+8.25%
6.6M
N/A
Total Current Liabilities
33.4M
+88.58%
17.7M
+5.21%
16.8M
N/A
Total Long-Term Debt
28.5M
+7.72%
26.5M
+54.06%
17.2M
N/A
Total Long-Term Liabilities
79,825
-99.55%
17.9M
+1.18%
17.7M
N/A
Total Liabilities
33.5M
+88.18%
17.8M
+4.72%
17.0M
N/A
Retained Earnings
-75.1M
+33.09%
-56.4M
+5.82%
-53.3M
N/A
Total Stockholders Equity
-32.2M
+104.00%
-15.8M
+9.74%
-14.4M
N/A
Total Shares Outstanding
213.2M
+186.22%
74.5M
+203.62%
24.5M
N/A
Cash Flow
Cash from Operating Activities
-678,838
-31.19%
-986,584
+33.04%
-741,590
N/A
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
N/A
N/A
N/A
N/A
N/A
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
593,000
-44.01%
1.1M
+43.88%
736,117
N/A
Financials Ratio
Gross Margin
92.62%
+16.50%
79.50%
+31.25%
60.57%
N/A
Operating Margin
-2,411.69%
-20.82%
-3,045.68%
+73.40%
-1,756.49%
N/A
Return on Assets
-1,123.61%
+734.91%
-134.58%
+900.48%
-13.45%
N/A
Return on Equity
77.05%
+274.08%
20.60%
+808.02%
2.27%
N/A
Revenue Growth
85.15%
+252.31%
-55.91%
+20.11%
-46.55%
N/A
Current Ratio
0.0005
-90.74%
0.005
+100.00%
0.003
N/A
Cash Ratio
0.00
-100.00%
0.005
+512.50%
0.0008
N/A
Debt-to-Equity Ratio
-1.11
-48.05%
-2.13
+28.75%
-1.66
N/A
Debt-to-Assets Ratio
27.83
+66.05%
16.76
+83.52%
9.13
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow